Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms
Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and tr...
Gespeichert in:
Veröffentlicht in: | Diagnostic microbiology and infectious disease 2019-11, Vol.95 (3), p.114860-114860, Article 114860 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 114860 |
---|---|
container_issue | 3 |
container_start_page | 114860 |
container_title | Diagnostic microbiology and infectious disease |
container_volume | 95 |
creator | de Menezes, Ramon R.P.P.B. Sampaio, Tiago L. Lima, Danya B. Sousa, Paloma L. de Azevedo, Isabella E.P. Magalhães, Emanuel P. Tessarolo, Louise D. Marinho, Márcia Machado dos Santos, Ricardo Pires Martins, Alice M.C. |
description | Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition.
[Display omitted]
•(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells. |
doi_str_mv | 10.1016/j.diagmicrobio.2019.06.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2266336197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0732889319306443</els_id><sourcerecordid>2266336197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</originalsourceid><addsrcrecordid>eNqNkD1OxDAQRi0EgmXhCsiigiJhbGfthA7xLyFRAAWV5Tg28iqJFzuLBCeg5iZchENwEox2QZRUU3zvm9E8hHYJ5AQIP5jmjVMPndPB187nFEiVA8-B0BU0IqWoMgABq2gEgtGsLCu2gTZjnEIiqgLW0QYjbMKA8xG6OeoHN1NBRTc4jY21Rg_YW7z3-fq2n328Z7WLqvatb7F6UK6PA74NzzPV--g7hXWYvzh8j-MQUoitD13cQmtWtdFsL-cY3Z2d3h5fZFfX55fHR1eZLhgdMgGmsZxoqCd1JYS1pa2LQmhmGzERiteiaixQUyiqDS-IaMoJtylhoGlJGBujvcXeWfCPcxMH2bmoTduq3vh5lJRyzhgnlUjo4QJNzmIMxspZcJ0Kz5KA_JYqp_KvVPktVQKXSVkq7yzvzOvONL_VH4sJOFkAJn375EyQUTvTa9O4kHTKxrv_3PkCcyCRFw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2266336197</pqid></control><display><type>article</type><title>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>de Menezes, Ramon R.P.P.B. ; Sampaio, Tiago L. ; Lima, Danya B. ; Sousa, Paloma L. ; de Azevedo, Isabella E.P. ; Magalhães, Emanuel P. ; Tessarolo, Louise D. ; Marinho, Márcia Machado ; dos Santos, Ricardo Pires ; Martins, Alice M.C.</creator><creatorcontrib>de Menezes, Ramon R.P.P.B. ; Sampaio, Tiago L. ; Lima, Danya B. ; Sousa, Paloma L. ; de Azevedo, Isabella E.P. ; Magalhães, Emanuel P. ; Tessarolo, Louise D. ; Marinho, Márcia Machado ; dos Santos, Ricardo Pires ; Martins, Alice M.C.</creatorcontrib><description>Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition.
[Display omitted]
•(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells.</description><identifier>ISSN: 0732-8893</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/j.diagmicrobio.2019.06.012</identifier><identifier>PMID: 31353066</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Apoptosis ; Apoptosis - drug effects ; Bisabolol ; Cell Line ; Cell Survival - drug effects ; Chagas Disease - drug therapy ; Chagas Disease - parasitology ; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists & inhibitors ; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism ; Inhibitory Concentration 50 ; Macaca mulatta ; Molecular Docking Simulation ; Molecular Structure ; Monocyclic Sesquiterpenes - chemistry ; Monocyclic Sesquiterpenes - pharmacology ; Oxidative Stress - drug effects ; Trypanocidal Agents - pharmacology ; Trypanosoma cruzi ; Trypanosoma cruzi - drug effects ; Trypanosoma cruzi - physiology</subject><ispartof>Diagnostic microbiology and infectious disease, 2019-11, Vol.95 (3), p.114860-114860, Article 114860</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</citedby><cites>FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.diagmicrobio.2019.06.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31353066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Menezes, Ramon R.P.P.B.</creatorcontrib><creatorcontrib>Sampaio, Tiago L.</creatorcontrib><creatorcontrib>Lima, Danya B.</creatorcontrib><creatorcontrib>Sousa, Paloma L.</creatorcontrib><creatorcontrib>de Azevedo, Isabella E.P.</creatorcontrib><creatorcontrib>Magalhães, Emanuel P.</creatorcontrib><creatorcontrib>Tessarolo, Louise D.</creatorcontrib><creatorcontrib>Marinho, Márcia Machado</creatorcontrib><creatorcontrib>dos Santos, Ricardo Pires</creatorcontrib><creatorcontrib>Martins, Alice M.C.</creatorcontrib><title>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition.
[Display omitted]
•(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Bisabolol</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Chagas Disease - drug therapy</subject><subject>Chagas Disease - parasitology</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists & inhibitors</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism</subject><subject>Inhibitory Concentration 50</subject><subject>Macaca mulatta</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Structure</subject><subject>Monocyclic Sesquiterpenes - chemistry</subject><subject>Monocyclic Sesquiterpenes - pharmacology</subject><subject>Oxidative Stress - drug effects</subject><subject>Trypanocidal Agents - pharmacology</subject><subject>Trypanosoma cruzi</subject><subject>Trypanosoma cruzi - drug effects</subject><subject>Trypanosoma cruzi - physiology</subject><issn>0732-8893</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1OxDAQRi0EgmXhCsiigiJhbGfthA7xLyFRAAWV5Tg28iqJFzuLBCeg5iZchENwEox2QZRUU3zvm9E8hHYJ5AQIP5jmjVMPndPB187nFEiVA8-B0BU0IqWoMgABq2gEgtGsLCu2gTZjnEIiqgLW0QYjbMKA8xG6OeoHN1NBRTc4jY21Rg_YW7z3-fq2n328Z7WLqvatb7F6UK6PA74NzzPV--g7hXWYvzh8j-MQUoitD13cQmtWtdFsL-cY3Z2d3h5fZFfX55fHR1eZLhgdMgGmsZxoqCd1JYS1pa2LQmhmGzERiteiaixQUyiqDS-IaMoJtylhoGlJGBujvcXeWfCPcxMH2bmoTduq3vh5lJRyzhgnlUjo4QJNzmIMxspZcJ0Kz5KA_JYqp_KvVPktVQKXSVkq7yzvzOvONL_VH4sJOFkAJn375EyQUTvTa9O4kHTKxrv_3PkCcyCRFw</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>de Menezes, Ramon R.P.P.B.</creator><creator>Sampaio, Tiago L.</creator><creator>Lima, Danya B.</creator><creator>Sousa, Paloma L.</creator><creator>de Azevedo, Isabella E.P.</creator><creator>Magalhães, Emanuel P.</creator><creator>Tessarolo, Louise D.</creator><creator>Marinho, Márcia Machado</creator><creator>dos Santos, Ricardo Pires</creator><creator>Martins, Alice M.C.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201911</creationdate><title>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</title><author>de Menezes, Ramon R.P.P.B. ; Sampaio, Tiago L. ; Lima, Danya B. ; Sousa, Paloma L. ; de Azevedo, Isabella E.P. ; Magalhães, Emanuel P. ; Tessarolo, Louise D. ; Marinho, Márcia Machado ; dos Santos, Ricardo Pires ; Martins, Alice M.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Bisabolol</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Chagas Disease - drug therapy</topic><topic>Chagas Disease - parasitology</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists & inhibitors</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism</topic><topic>Inhibitory Concentration 50</topic><topic>Macaca mulatta</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Structure</topic><topic>Monocyclic Sesquiterpenes - chemistry</topic><topic>Monocyclic Sesquiterpenes - pharmacology</topic><topic>Oxidative Stress - drug effects</topic><topic>Trypanocidal Agents - pharmacology</topic><topic>Trypanosoma cruzi</topic><topic>Trypanosoma cruzi - drug effects</topic><topic>Trypanosoma cruzi - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Menezes, Ramon R.P.P.B.</creatorcontrib><creatorcontrib>Sampaio, Tiago L.</creatorcontrib><creatorcontrib>Lima, Danya B.</creatorcontrib><creatorcontrib>Sousa, Paloma L.</creatorcontrib><creatorcontrib>de Azevedo, Isabella E.P.</creatorcontrib><creatorcontrib>Magalhães, Emanuel P.</creatorcontrib><creatorcontrib>Tessarolo, Louise D.</creatorcontrib><creatorcontrib>Marinho, Márcia Machado</creatorcontrib><creatorcontrib>dos Santos, Ricardo Pires</creatorcontrib><creatorcontrib>Martins, Alice M.C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Menezes, Ramon R.P.P.B.</au><au>Sampaio, Tiago L.</au><au>Lima, Danya B.</au><au>Sousa, Paloma L.</au><au>de Azevedo, Isabella E.P.</au><au>Magalhães, Emanuel P.</au><au>Tessarolo, Louise D.</au><au>Marinho, Márcia Machado</au><au>dos Santos, Ricardo Pires</au><au>Martins, Alice M.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>2019-11</date><risdate>2019</risdate><volume>95</volume><issue>3</issue><spage>114860</spage><epage>114860</epage><pages>114860-114860</pages><artnum>114860</artnum><issn>0732-8893</issn><eissn>1879-0070</eissn><abstract>Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition.
[Display omitted]
•(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31353066</pmid><doi>10.1016/j.diagmicrobio.2019.06.012</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0732-8893 |
ispartof | Diagnostic microbiology and infectious disease, 2019-11, Vol.95 (3), p.114860-114860, Article 114860 |
issn | 0732-8893 1879-0070 |
language | eng |
recordid | cdi_proquest_miscellaneous_2266336197 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Animals Apoptosis Apoptosis - drug effects Bisabolol Cell Line Cell Survival - drug effects Chagas Disease - drug therapy Chagas Disease - parasitology Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists & inhibitors Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism Inhibitory Concentration 50 Macaca mulatta Molecular Docking Simulation Molecular Structure Monocyclic Sesquiterpenes - chemistry Monocyclic Sesquiterpenes - pharmacology Oxidative Stress - drug effects Trypanocidal Agents - pharmacology Trypanosoma cruzi Trypanosoma cruzi - drug effects Trypanosoma cruzi - physiology |
title | Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A54%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiparasitic%20effect%20of%20(%E2%88%92)-%CE%B1-bisabolol%20against%20Trypanosoma%20cruzi%20Y%20strain%20forms&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=de%20Menezes,%20Ramon%20R.P.P.B.&rft.date=2019-11&rft.volume=95&rft.issue=3&rft.spage=114860&rft.epage=114860&rft.pages=114860-114860&rft.artnum=114860&rft.issn=0732-8893&rft.eissn=1879-0070&rft_id=info:doi/10.1016/j.diagmicrobio.2019.06.012&rft_dat=%3Cproquest_cross%3E2266336197%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2266336197&rft_id=info:pmid/31353066&rft_els_id=S0732889319306443&rfr_iscdi=true |